Oxfendazole
Spezifikationen
53716-50-0CAS-Nummer
258-714-5EG-Nummer
methyl N-[6-(benzenesulfinyl)-1H-benzimidazol-2-yl]carbamateIUPAC-Name
C15H13N3O3SChemische Formel
315.3 g/molMolekulargewicht
Oxfendazole; 53716-50-0; Fenbendazole sulfoxide; Synanthic; OFDZ; Oxfendazol; Oxfendazolum; fenbendazole S-oxide; RS-8858; 5-Phenylsulfinyl-2-carbomethoxyaminobenzimidazole; DTXSID9044112; 5-(Phenylsulfinyl)-2-benzimidazolecarbamic acid methyl ester; (5-(Phenylsulfinyl)-1H-benzimidazol-2-yl)carbamic acid methyl ester; OMP2H17F9E; NSC-758943; [5-(Phenylsulfinyl)-1H-benzimidazol-2-yl]carbamic acid methyl ester; methyl 5(6)-phenylsulfinyl-2-benzimidazolecarbamate; DTXCID7024112; CHEBI:35812; FBZ-SO; methyl N-[5-(benzenesulfinyl)-1H-1,3-benzodiazol-2-yl]carbamate; methyl N-(5-(benzenesulfinyl)-1H-1,3-benzodiazol-2-yl)carbamate; Benzelmin Top Dress.; RefChem:57221; Synanthic Bovine Dewormer; Benzelmin Powder For Suspension; Synanthic Bovine Dewormer Paste, 18.5%; Benzelmin Equine Anthelmic Paste, Synanthic Oral Paste; Benzelmin Equine Anthelmintic Suspension, Synanthic Suspension; Synanthic Bovine Dewormer Suspension 22.5%, Synanthic Bovine Dewormer Suspension 9.06%; 258-714-5; Systamex; Repidose; Systemax; Synanthic (Veterinary); methyl N-[6-(benzenesulfinyl)-1H-benzimidazol-2-yl]carbamate; RS 8858; Methyl 5-(phenylsulfinyl)-2-benzimidazolecarbamate; MFCD00801063; Oxfendazole (USP/INN); methyl [5-(phenylsulfinyl)-1H-benzimidazol-2-yl]carbamate; methyl (6-(phenylsulfinyl)-1H-benzo[d]imidazol-2-yl)carbamate; CHEMBL42442; Methyl (5-phenylsulfinyl)-1H-benzimidazol-2-yl carbamate; Carbamic acid, [5-(phenylsulfinyl)-1H-benzimidazol-2-yl]-, methyl ester; NCGC00095157-04; Carbamic acid, 5-(phenylsulfinyl)-1H-benzimidazol-2-yl-, methyl ester; CARBAMIC ACID, (5-(PHENYLSULFINYL)-1H-BENZIMIDAZOL-2-YL)-, METHYL ESTER; Methyl [5-(Phenylsulfinyl)benzimidazol-2-yl]carbamate; methyl N-[5-(benzenesulfinyl)-1H-benzimidazol-2-yl]carbamate; [5-(Phenylsulfinyl)benzimidazol-2-yl]carbamic Acid Methyl Ester; Oxfendazol [INN-Spanish]; Oxfendazolum [INN-Latin]; HOE 8105; CAS-53716-50-0; Oxfendazole [USAN:BAN:INN]; Fenbendazole sulphoxide; EINECS 258-714-5; UNII-OMP2H17F9E; Methyl 5-(phenylsulfinyl)-benzimidazol-2-carbamate; BRN 0761290; Fenbendazole Sulphoxide; Oxfendazole; Fenbendazole Sulfoxide; Benzelmin; Nanthic; CCRIS 9430; Oxfendazole CRS; Synanthic (TN); OxFBZ; Oxfendazole [USAN:USP:INN:BAN]; Oxfendazole (Standard); 2-Benzimidazolecarbamic acid, 5-(phenylsulfinyl)-, methyl ester; OXFENDAZOLE [MI]; Spectrum2_001704; Spectrum3_001972; OXFENDAZOLE [INN]; OXFENDAZOLE [USAN]; OXFENDAZOLE [MART.]; Oprea1_563224; SCHEMBL44121; BSPBio_003572; OXFENDAZOLE [USP-RS]; MLS004712073; Synanthic [veterinary] (TN); SPECTRUM1505296; SPBio_001688; orb1310358; orb3025229; SCHEMBL9818561; OXFENDAZOLE [GREEN BOOK]; Oxfendazole with impurity D CRS; SCHEMBL29351297; SCHEMBL29409244; HY-B0291R; KBio3_002947; MSK5561; HMS1922B08; HMS2090F19; HMS2093O16; HMS3655M14; HMS3715E09; HMS5080C13; Pharmakon1600-01505296; OXFENDAZOLE [USP MONOGRAPH]; HY-B0291; Oxfendazole (Fenbendazole Sulfoxide); Tox21_113444; Tox21_302383; BDBM50300124; CCG-39503; MSK5561-100M; NSC758943; s1830; Fenbendazole Sulphoxide (Oxfendazole); AKOS005448898; AKOS015918230; MSK5561-1000D; MSK5561-1000M; Tox21_113444_1; AC-8715; CCG-220984; DB11446; FF23244; KS-5036; NSC 758943; NCGC00095157-01; NCGC00095157-02; NCGC00095157-03; NCGC00095157-05; NCGC00095157-06; NCGC00255714-01; Oxfendazole 100 |Ig/mL in Acetonitrile; SMR001550468; SY052761; Oxfendazole 100 microg/mL in Acetonitrile; Oxfendazole Solution in DMSO, 1000ug/mL; SBI-0206760.P001; DB-052387; NS00010597; O0391; O9322; Oxfendazole Solution in Methanol, 100ug/mL; ST50865840; SW199450-2; Oxfendazole for veterinary use [EP monograph]; Oxfendazole Solution in Methanol, 1000ug/mL; C21882; D05291; AB01275512-01; AB01275512_02; AB01275512_03; Oxfendazole, VETRANAL(TM), analytical standard; F828265; SR-01000872713; Q7115199; SR-01000872713-1; BRD-A33447119-001-02-5; BRD-A33447119-001-03-3; BRD-A33447119-001-05-8; BRD-A33447119-001-10-8; BRD-A33447119-001-11-6; Methyl [6-(Phenylsulfinyl)-2-benzimidazolyl]carbamate; methoxy-N-[5-(phenylsulfinyl)benzimidazol-2-yl]carboxamide; Oxfendazole, European Pharmacopoeia (EP) Reference Standard; methyl (5-(phenylsulfinyl)-1H-benzo[d]imidazol-2-yl)carbamate; METHYL 6-(PHENYLSULFINYL)-1H-BENZIMIDAZOL-2-YLCARBAMATE; Methyl [5-(benzenesulfinyl)-1H-1,3-benzimidazol-2-yl]carbamate; Methyl [5-(phenylsulfinyl)-1H-benzimidazol-2-yl]carbamate, 9CI; methyl N-[6-(benzenesulfinyl)-1H-1,3-benzodiazol-2-yl]carbamate; Oxfendazole, United States Pharmacopeia (USP) Reference Standard; Carbamic acid, N-[5-(phenylsulfinyl)-1H-benzimidazol-2-yl]-, methyl ester; Carbamic acid, N-[6-(phenylsulfinyl)-1H-benzimidazol-2-yl]-, methyl esterSynonyme
Produkte, die Oxfendazole enthalten
Unternehmen, die Oxfendazole verkaufen
HT
Hebei Teamtop Pharmaceutical Co.,LtdChinaTE
TIANJIN ENJU BIOTECHNOLOGY CO., LTD.ChinaHS
Hepta Sciences Co,. Limited
CE
Chifeng Eyeris Company Ltd.,MongoliaAC
AFINE CHEMICALS LIMITED